Integer (NYSE:ITGR) Stock Rating Reaffirmed by Benchmark

Integer (NYSE:ITGR)‘s stock had its “buy” rating reaffirmed by Benchmark in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $130.00 price target on the medical equipment provider’s stock. Benchmark’s price target indicates a potential upside of 2.23% from the stock’s previous close.

A number of other analysts also recently issued reports on ITGR. Citigroup lifted their price target on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Tuesday. Oppenheimer started coverage on shares of Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target for the company. Bank of America upped their target price on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday. Finally, Truist Financial lifted their price target on Integer from $137.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Integer has a consensus rating of “Moderate Buy” and an average target price of $137.29.

Integer Price Performance

Shares of Integer stock traded down $0.02 on Wednesday, reaching $127.17. The stock had a trading volume of 5,223 shares, compared to its average volume of 315,817. The business’s 50 day moving average is $123.37 and its two-hundred day moving average is $119.31. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. The company has a market cap of $4.26 billion, a P/E ratio of 44.03, a price-to-earnings-growth ratio of 1.87 and a beta of 1.09. Integer has a 1 year low of $69.40 and a 1 year high of $131.87.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. The firm had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.14 EPS. As a group, research analysts anticipate that Integer will post 5.31 EPS for the current year.

Insiders Place Their Bets

In related news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Integer

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in Integer by 0.6% during the first quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock valued at $446,428,000 after buying an additional 23,382 shares during the period. Earnest Partners LLC increased its stake in shares of Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after acquiring an additional 37,340 shares in the last quarter. Congress Asset Management Co. MA lifted its position in Integer by 7.5% during the 1st quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after acquiring an additional 31,736 shares during the period. Driehaus Capital Management LLC boosted its stake in Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after acquiring an additional 135,750 shares in the last quarter. Finally, Tributary Capital Management LLC grew its holdings in Integer by 0.3% in the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock worth $33,168,000 after purchasing an additional 772 shares during the period. Institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.